Are you Dr. Bazinet?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 4 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
1515 Holcombe Blvd
Houston, TX 77030Phone+1 713-792-6161
Education & Training
- McGill University Faculty of MedicineClass of 2014
Certifications & Licensure
- TX State Medical License 2023 - 2024
Publications & Presentations
PubMed
- 40 citationsAzacitidine plus venetoclax in patients with high-risk myelodysplastic syndromes or chronic myelomonocytic leukaemia: phase 1 results of a single-centre, dose-escalati...Alexandre Bazinet, Faezeh Darbaniyan, Elias Jabbour, Guillermo Montalban-Bravo, Maro Ohanian
The Lancet. Haematology. 2022-10-01 - 13 citationsCharacteristics and clinical outcomes of patients with myeloid malignancies and DDX41 variants.Alex Bataller, Sanam Loghavi, Yoheved Gerstein, Alexandre Bazinet, Koji Sasaki
American Journal of Hematology. 2023-11-01 - 9 citationsPrognostic risk signature in patients with acute myeloid leukemia treated with hypomethylating agents and venetoclax.Alex Bataller, Alexandre Bazinet, Courtney D DiNardo, Abhishek Maiti, Gautam Borthakur
Blood Advances. 2024-02-27
Press Mentions
- MD Anderson Research Highlights for March 20, 2024March 21st, 2024
- MD Anderson Research Highlights for April 12, 2024April 13th, 2024